Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders

References

• Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23.
   PubMed Web of Science ®Google Scholar
• Goutman SA, Chen KS, Paez-Colasante X, Feldman EL. Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis. Handb Clin Neurol 2018;148:603–23.
   PubMedGoogle Scholar
• Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL. Genetics of amyotrophic lateral sclerosis: A review. J Neurol Sci. 2019;399:217–26.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13:96–104.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540–9.
   PubMed Web of Science ®Google Scholar
• Van Daele SH, Moisse M, Van Vugt JJFA, Zwamborn RAJ, Van der Spek R, Van Rheenen W, et al. Genetic variability in sporadic amyotrophic lateral sclerosis. Brain. 2023;146:3760–9.
   PubMed Web of Science ®Google Scholar
• Van Blitterswijk M, Van Es MA, Hennekam EA, Dooijes D, Van Rheenen W, Medic J, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:3776–84.
   PubMed Web of Science ®Google Scholar
• Olsen CG, Busk ØL, Aanjesen TN, Alstadhaug KB, Bjørnå IK, Braathen GJ, et al. Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study. Neuroepidemiology 2022;56:271–82.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81:1324–6.
   PubMed Web of Science ®Google Scholar
• Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2019;76:1367–74.
   PubMed Web of Science ®Google Scholar
• Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology 2012;79:1002–11.
   PubMed Web of Science ®Google Scholar
• Bourinaris T, Houlden H. C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature. Mov Disord Clin Pract. 2018;5:575–85.
   PubMed Web of Science ®Google Scholar
• Ducharme S, Bajestan S, Dickerson BC, Voon V. Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians? J Neuropsychiatry Clin Neurosci. 2017;29:195–205.
   PubMed Web of Science ®Google Scholar
• Kirola L, Mukherjee A, Mutsuddi M. Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Mol Neurobiol. 2022;59:5673–94.
   PubMed Web of Science ®Google Scholar
• Van Es MA, Schelhaas HJ, Van Vught PWJ, Ticozzi N, Andersen PM, Groen EJN, et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol. 2011;70:964–73.
   PubMed Web of Science ®Google Scholar
• Morais S, Raymond L, Mairey M, Coutinho P, Brandão E, Ribeiro P, et al. Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. Eur J Hum Genet. 2017;25:1217–28.
   PubMed Web of Science ®Google Scholar
• Crimella C, Baschirotto C, Arnoldi A, Tonelli A, Tenderini E, Airoldi G, et al. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet. 2012;82:157–64.
   PubMed Web of Science ®Google Scholar
• Online Mendelian Inheritance in Man. OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD): 1995 [cited 2023 Jan 10]. Available from: https://omim.org/.
   Google Scholar
• Siddique N, Siddique T, Amyotrophic Lateral Sclerosis Overview. In: Adam M, Everman D, Mirzaa G, Pagon R, Wallace S, Bean L, et al. editors. 2023. GeneReviews [Internet]: Seattle (WA): University of Washington, Seattle; 1993–2023.; 2001 Mar 23 [Updated 2021 Sep 30].
   Google Scholar
• Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:480–93.
   PubMed Web of Science ®Google Scholar
• Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465–79.
   PubMed Web of Science ®Google Scholar
• Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020;581:434–43.
   PubMed Web of Science ®Google Scholar
• Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The Human Gene Mutation Database (HGMD(®)): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139:1197–207.
   PubMed Web of Science ®Google Scholar
• Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet. 2016;99:877–85.
   PubMed Web of Science ®Google Scholar
• Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062–D1067.
   PubMed Web of Science ®Google Scholar
• Van Rheenen W, Pulit SL, Dekker AM, Al Khleifat A, Brands WJ, Iacoangeli A, et al. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet 2018;26:1537–46.
   PubMed Web of Science ®Google Scholar
• Stenson PD, Ball E, Howells K, Phillips A, Mort M, Cooper DN. Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet. 2008;45:124–6.
   PubMed Web of Science ®Google Scholar
• Coutelier M, Hammer MB, Stevanin G, Monin ML, Davoine CS, Mochel F, et al. Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes. JAMA Neurol. 2018;75:591–9.
   PubMed Web of Science ®Google Scholar
• Calandra CR, Buda G, Vishnopolska SA, Oliveri J, Olivieri FA, Pérez Millán MI, et al. Spastic ataxia with eye-of-the-tiger-like sign in 4 siblings due to novel compound heterozygous AFG3L2 mutation. Parkinsonism Relat Disord. 2020;73:52–4.
   PubMed Web of Science ®Google Scholar
• Davis RL, Kumar KR, Puttick C, Liang C, Ahmad KE, Edema-Hildebrand F, et al. Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis. Neurology 2022;99:e730–e742.
   PubMed Web of Science ®Google Scholar
• Galatolo D, De Michele G, Silvestri G, Leuzzi V, Casali C, Musumeci O, et al. NGS in Hereditary Ataxia: When Rare Becomes Frequent. Int J Mol Sci 2021;22:8490.
   PubMed Web of Science ®Google Scholar
• Musova Z, Kaiserova M, Kriegova E, Fillerova R, Vasovcak P, Santava A, et al. A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia. Cerebellum. 2014;13:331–7.
   PubMed Web of Science ®Google Scholar
• Liao P, Yuan Y, Liu Z, Hou X, Li W, Wen J, et al. Association of variants in the KIF1A gene with amyotrophic lateral sclerosis. Transl Neurodegener. 2022;11:46.
   PubMed Web of Science ®Google Scholar
• Pennings M, Schouten MI, Van Gaalen J, Meijer RPP, de Bot ST, Kriek M, et al. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia. Eur J Hum Genet. 2020;28:40–9.
   PubMed Web of Science ®Google Scholar
• Nicita F, Ginevrino M, Travaglini L, D'Arrigo S, Zorzi G, Borgatti R, et al. Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders. J Med Genet. 2021;58:475–83.
   PubMed Web of Science ®Google Scholar
• Tolosa E, Vila M, Klein C, Rascol O. LRRK2 in Parkinson disease: challenges of clinical trials. Nat Rev Neurol. 2020;16:97–107.
   PubMed Web of Science ®Google Scholar
• Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, et al. Clinical features of LRRK2-associated Parkinson’s disease in central Norway. Ann Neurol. 2005;57:762–5.
   PubMed Web of Science ®Google Scholar
• Nasca A, Scotton C, Zaharieva I, Neri M, Selvatici R, Magnusson OT, et al. Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia. Hum Mutat. 2017;38:970–7.
   PubMed Web of Science ®Google Scholar
• Kenna KP, Van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48:1037–42.
   PubMed Web of Science ®Google Scholar
• Naruse H, Ishiura H, Mitsui J, Takahashi Y, Matsukawa T, Yoshimura J, et al. Loss-of-function variants in NEK1 are associated with an increased risk of sporadic ALS in the Japanese population. J Hum Genet. 2021;66:237–41.
   PubMed Web of Science ®Google Scholar
• Brenner D, Müller K, Wieland T, Weydt P, Böhm S, Lulé D, et al. NEK1 mutations in familial amyotrophic lateral sclerosis. Brain. 2016;139:e28–e28.
   PubMed Web of Science ®Google Scholar
• Verheijen J, Van den Bossche T, Van der Zee J, Engelborghs S, Sanchez-Valle R, Lladó A, et al. A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease. Acta Neuropathol. 2016;132:213–24.
   PubMed Web of Science ®Google Scholar
• Nicolas G, Charbonnier C, Wallon D, Quenez O, Bellenguez C, Grenier-Boley B, et al. SORL1 rare variants: a major risk factor for familial early-onset Alzheimer’s disease. Mol Psychiatry. 2016;21:831–6.
   PubMed Web of Science ®Google Scholar
• Bellenguez C, Charbonnier C, Grenier-Boley B, Quenez O, Le Guennec K, Nicolas G, et al. Contribution to Alzheimer’s disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls. Neurobiol Aging 2017;59:e1–e9.
   PubMed Web of Science ®Google Scholar
• Bakkar N, Starr A, Rabichow BE, Lorenzini I, McEachin ZT, Kraft R, et al. The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease. Neurobiol Dis. 2021;149:105228.
   PubMed Web of Science ®Google Scholar
• Wan C, Wang Y, Zhou Q, Yu Y, Hong D, Zhu M. Adult-onset SMALED2 due to a novel BICD2 mutation presenting with asymmetrical lower limb involvement. Clin Neuropathol. 2019;38:109–17.
   PubMed Web of Science ®Google Scholar
• D'Amore A, Tessa A, Casali C, Dotti MT, Filla A, Silvestri G, et al. Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study. Front Neurol. 2018;9:981.
   PubMed Web of Science ®Google Scholar
• Didonna A, Opal P. The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders. Mol Neurodegener 2019;14:1–10.
   PubMed Web of Science ®Google Scholar
• Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet. 1994;3:1757–61.
   PubMed Web of Science ®Google Scholar
• Rooke K, Figlewicz DA, Han FY, Rouleau GA. Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis. Neurology 1996;46:789–90.
   PubMed Web of Science ®Google Scholar
• Marriott H, Spargo TP, Khleifat AA, Fogh I, Consortium PMAS, Andersen PM, et al. Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis. medRxiv 2022;2022:11.
   Google Scholar
• Campos CF, Gromicho M, Uysal H, Grosskreutz J, Kuzma-Kozakiewicz M, Pinto S, et al. Family history of neurodegenerative disorders in patients with amyotrophic lateral sclerosis: population-based case–control study. J Neurol Neurosurg Psychiatry. 2020;91:671–2.
   PubMed Web of Science ®Google Scholar
• Cruz DC, Nelson LM, McGuire V, Longstreth WT. Physical Trauma and Family History of Neurodegenerative Diseases in Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study. Neuroepidemiology 1999;18:101–10.
   PubMed Web of Science ®Google Scholar
• Huisman MHB, de Jong SW, Verwijs MC, Schelhaas HJ, van der Kooi AJ, de Visser M, et al. Family history of neurodegenerative and vascular diseases in ALS: a population-based study. Neurology 2011;77:1363–9.
   PubMed Web of Science ®Google Scholar
• Fallis BA, Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds. Amyotroph Lateral Scler. 2009;10:95–8.
   PubMed Web of Science ®Google Scholar
• Almontashiri NA, Chen HH, Mailloux RJ, Tatsuta T, Teng AC, Mahmoud AB, et al. SPG7 variant escapes phosphorylation-regulated processing by AFG3L2, elevates mitochondrial ROS, and is associated with multiple clinical phenotypes. Cell Rep. 2014;7:834–47.
   PubMed Web of Science ®Google Scholar
• Osmanovic A, Widjaja M, Förster A, Weder J, Wattjes MP, Lange I, et al. SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia. J Neurol. 2020;267:2732–43.
   PubMed Web of Science ®Google Scholar
• Sleigh JN, Rossor AM, Fellows AD, Tosolini AP, Schiavo G. Axonal transport and neurological disease. Nat Rev Neurol. 2019;15:691–703.
   PubMed Web of Science ®Google Scholar
• Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 2018;97:1268–83.e6.
   PubMed Web of Science ®Google Scholar
• Lissouba A, Liao M, Kabashi E, Drapeau P. Transcriptomic Analysis of Zebrafish TDP-43 Transgenic Lines. Front Mol Neurosci. 2018;11:463.
   PubMed Web of Science ®Google Scholar
• Kaler SG, DiStasio AT, ATP7A-Related Copper Transport Disorders. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, et al. editors. GeneReviews. Seattle (WA): University of Washington, Seattle, 1993–2023; 1993.
   Google Scholar
• Aziz I, Davis M, Liang C. Late adult-onset spinal muscular atrophy with lower extremity predominance (SMALED). BMJ Case Rep 2022;15:e248297.
   PubMedGoogle Scholar
• Mentis AA, Vlachakis D, Papakonstantinou E, Zaganas I, Patrinos GP, Chrousos GP, et al. A novel variant in DYNC1H1 could contribute to human amyotrophic lateral sclerosis-frontotemporal dementia spectrum. Cold Spring Harb Mol Case Stud 2022;8:a006096.
   PubMed Web of Science ®Google Scholar
• Scarlino S, Domi T, Pozzi L, Romano A, Pipitone GB, Falzone YM, et al. Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort. Int J Mol Sci 2020;21:3346.
   PubMed Web of Science ®Google Scholar
• Tripolszki K, Gampawar P, Schmidt H, Nagy ZF, Nagy D, Klivényi P, et al. Comprehensive Genetic Analysis of a Hungarian Amyotrophic Lateral Sclerosis Cohort. Front Genet. 2019;10:732.
   PubMed Web of Science ®Google Scholar
• Borg R, Farrugia Wismayer M, Bonavia K, Farrugia Wismayer A, Vella M, Van Vugt J, et al. Genetic analysis of ALS cases in the isolated island population of Malta. Eur J Hum Genet. 2021;29:604–14.
   PubMed Web of Science ®Google Scholar
• Collard JF, Côté F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995;375:61–4.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet. 1999;8:157–64.
   PubMed Web of Science ®Google Scholar
• Grassano M, Calvo A, Moglia C, Sbaiz L, Brunetti M, Barberis M, et al. Systematic evaluation of genetic mutations in ALS: a population-based study. J Neurol Neurosurg Psychiatry. 2022;93:1190–3.
   PubMed Web of Science ®Google Scholar
• Shepheard SR, Parker MD, Cooper-Knock J, Verber NS, Tuddenham L, Heath P, et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;92:510–8.
   PubMed Web of Science ®Google Scholar
• Yao L, He X, Cui B, Zhao F, Zhou C. NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis. Neurol Sci. 2021;42:1277–85.
   PubMed Web of Science ®Google Scholar
• Check Hayden E. Humans riddled with rare genetic variants. Nature (London). 2012. https://doi.org/10.1038/nature.2012.10655
   Google Scholar
• Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016;536:285–91.
   PubMed Web of Science ®Google Scholar